Body mass index and blood pressure changes over the course of treatment of pediatric acute lymphoblastic leukemia.
Pediatr Blood Cancer. 2011.
PMID: 20860019
Free PMC article.
Search Page
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1946 | 1 |
| 1947 | 3 |
| 1948 | 2 |
| 1949 | 1 |
| 1950 | 2 |
| 1951 | 3 |
| 1952 | 2 |
| 1953 | 1 |
| 1954 | 1 |
| 1956 | 2 |
| 1957 | 2 |
| 1958 | 1 |
| 1959 | 2 |
| 1960 | 2 |
| 1961 | 1 |
| 1962 | 3 |
| 1963 | 6 |
| 1964 | 7 |
| 1965 | 4 |
| 1967 | 1 |
| 1969 | 1 |
| 1970 | 2 |
| 1972 | 1 |
| 1975 | 1 |
| 1976 | 2 |
| 1977 | 6 |
| 1979 | 5 |
| 1980 | 4 |
| 1981 | 5 |
| 1982 | 2 |
| 1983 | 6 |
| 1984 | 6 |
| 1985 | 9 |
| 1986 | 29 |
| 1987 | 64 |
| 1988 | 365 |
| 1989 | 706 |
| 1990 | 763 |
| 1991 | 748 |
| 1992 | 790 |
| 1993 | 784 |
| 1994 | 781 |
| 1995 | 737 |
| 1996 | 743 |
| 1997 | 761 |
| 1998 | 734 |
| 1999 | 723 |
| 2000 | 744 |
| 2001 | 740 |
| 2002 | 781 |
| 2003 | 850 |
| 2004 | 849 |
| 2005 | 951 |
| 2006 | 933 |
| 2007 | 979 |
| 2008 | 1083 |
| 2009 | 1209 |
| 2010 | 1315 |
| 2011 | 1469 |
| 2012 | 1488 |
| 2013 | 1494 |
| 2014 | 1622 |
| 2015 | 1591 |
| 2016 | 1613 |
| 2017 | 1638 |
| 2018 | 1621 |
| 2019 | 1625 |
| 2020 | 1256 |
| 2021 | 54 |
Search Results
31,699
results
Results by year
Citations
1 article found by citation matchingSearch results
Filters applied: . Clear all
Page 1
Showing results for
body mass index and blood pressure changes over the course of treatment or pediatric acute lymphoblastic leukemia
Search for
Body Mass Index and Blood Pressure Changes over the Course of Treatment of Pediatric Acute Lymphoblastic Leukemia
instead
(1 results)
Treatment and biology of pediatric acute lymphoblastic leukemia.
Pediatr Int. 2018 Jan;60(1):4-12. doi: 10.1111/ped.13457.
Pediatr Int. 2018.
PMID: 29143423
Review.
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. ...Treatment for pediatric ALL typically consists of induction therapy with steroids, vincristine, and asparaginase with or without anthracycline, followed …
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. ...Treatment for pediatric …
Advances in adult acute lymphoblastic leukemia therapy.
Leuk Lymphoma. 2018 May;59(5):1033-1050. doi: 10.1080/10428194.2017.1354372. Epub 2017 Jul 26.
Leuk Lymphoma. 2018.
PMID: 28745565
Review.
Progress in adult acute lymphoblastic leukemia (ALL) treatment has been met with challenge until recently. ...In this review, we will discuss the most significant advances in treating adult ALL observed in the last five years that have the potential to …
Progress in adult acute lymphoblastic leukemia (ALL) treatment has been met with challenge until recently. ...In …
Immunotherapy in pediatric acute lymphoblastic leukemia.
Cancer Metastasis Rev. 2019 Dec;38(4):595-610. doi: 10.1007/s10555-019-09834-0.
Cancer Metastasis Rev. 2019.
PMID: 31811553
Free PMC article.
Review.
The 5-year survival rate for children and adolescents with acute lymphoblastic leukemia (ALL) has improved to more than 90% in high-income countries. ...For immunotherapy, the approval of antibody-based therapy (with blinatumomab in 2014 and inotuzumab …
The 5-year survival rate for children and adolescents with acute lymphoblastic leukemia (ALL) has improved to more than …
Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances.
Curr Hematol Malig Rep. 2016 Oct;11(5):385-94. doi: 10.1007/s11899-016-0337-y.
Curr Hematol Malig Rep. 2016.
PMID: 27502091
Review.
While the majority of children and adolescents with newly diagnosed childhood acute lymphoblastic leukemia (ALL) will be cured, as many as 20 % of patients will experience relapse. On current treatment regimens, the intensity of upfront treatment …
While the majority of children and adolescents with newly diagnosed childhood acute lymphoblastic leukemia (ALL) will b …
Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment.
Eur J Haematol. 2016 May;96(5):447-60. doi: 10.1111/ejh.12722. Epub 2016 Jan 24.
Eur J Haematol. 2016.
PMID: 26679753
Review.
Lymphoblastic lymphoma is a rare aggressive neoplasm of T-/B-precursors resembling acute lymphoblastic leukemia, with no or limited bone marrow involvement (<25%), that develops more frequently in children and young adults and is typically ch …
Lymphoblastic lymphoma is a rare aggressive neoplasm of T-/B-precursors resembling acute lymphoblastic leukem …
New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.
Expert Rev Anticancer Ther. 2017 Aug;17(8):725-736. doi: 10.1080/14737140.2017.1347507. Epub 2017 Jul 5.
Expert Rev Anticancer Ther. 2017.
PMID: 28649891
Free PMC article.
Review.
The improvement in outcomes for children with acute lymphoblastic leukemia (ALL) is one of the greatest success stories of modern oncology however the prognosis for patients who relapse remains dismal. Recent discoveries by high resolution genomic technologie …
The improvement in outcomes for children with acute lymphoblastic leukemia (ALL) is one of the greatest success stories …
Genomics and pharmacogenomics of pediatric acute lymphoblastic leukemia.
Crit Rev Oncol Hematol. 2018 Jun;126:100-111. doi: 10.1016/j.critrevonc.2018.04.002. Epub 2018 Apr 10.
Crit Rev Oncol Hematol. 2018.
PMID: 29759551
Review.
Acute lymphoblastic leukaemia (ALL) is a prevalent form of pediatric cancer that accounts for 70-80% of all leukemias. ...The other ALLs include Early T-cell precursor ALL, Philadelphia chromosome-like ALL, Down syndrome-associated ALL and Relap …
Acute lymphoblastic leukaemia (ALL) is a prevalent form of pediatric cancer that accounts for 70-80% of all leukemias. …
Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia.
J Pediatr. 2018 Dec;203:14-24.e2. doi: 10.1016/j.jpeds.2018.07.039. Epub 2018 Sep 10.
J Pediatr. 2018.
PMID: 30213460
Free PMC article.
Review.
No abstract available.
Epigenetics in pediatric acute lymphoblastic leukemia.
Semin Cancer Biol. 2018 Aug;51:129-138. doi: 10.1016/j.semcancer.2017.09.001. Epub 2017 Sep 5.
Semin Cancer Biol. 2018.
PMID: 28887175
Free article.
Review.
Acute lymphoblastic leukemia (ALL) is the most common malignancy in children. ...Recent technical advances and decreasing costs of methods for high-throughput DNA sequencing and SNP genotyping have stimulated systematic studies of the epigenetic changes …
Acute lymphoblastic leukemia (ALL) is the most common malignancy in children. ...Recent technical advances and decreasi …
New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia.
Cancer. 2015 Aug 1;121(15):2517-28. doi: 10.1002/cncr.29383. Epub 2015 Apr 17.
Cancer. 2015.
PMID: 25891003
Free article.
Review.
Significant advances have been made in the last decade toward a better understanding of the disease pathogenesis and the development of novel therapies that target specific subsets of adult acute lymphoblastic leukemia (ALL). Risk-adapted strategies are trans …
Significant advances have been made in the last decade toward a better understanding of the disease pathogenesis and the development of nove …